Status: Recruiting
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
A Phase 2 Multi-center Open-label Trial of nab-Sirolimus in Combination with Letrozole in Advanced or Recurrent Endometrioid Endometrial Cancer
Participants needed: 29
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Aadi Bioscience, Inc.Updated: Nov 13, 2025Locations: 9
Eligibility criteria
Patients must have clinically confirmed advanced or recurrent endometrioid endom... [+23]
Prior treatment with an mTOR inhibitor, including nab-sirolimus. [+12]